Coronary stent thrombosis

Coronary stent thrombosis Microchapters
Home
Introduction
Definition
Epidemiology and Demographics
Relation to Bare Metal Stents
Relation to Drug Eluting Stents
Relation to Antiplatelet Medications
Pathophysiology
Risk Factors
Relationship to Discontinuation of Antiplatelet Therapy
Treatment
Complications
Prevention
Coronary stent thrombosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coronary stent thrombosis
CDC onCoronary stent thrombosis
Coronary stent thrombosis in the news
Blogs on Coronary stent thrombosis
to Hospitals Treating Coronary stent thrombosis
Risk calculators and risk factors for Coronary stent thrombosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editors-In-Chief: William J Gibson, Harvard Medical School; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Definition

Overview | Issues with interpreting data | Definition based on timing of ST | Definition based on certainty of ST

Incidence

Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Sirolimus eluting stent vs Paclitaxel eluting stent | Relation to antiplatelet medications

Mechanism and Pathophysiology

Overview | Mechanisms and pathophysiology | Clinical trial data

Etiology

Predictors of stent thrombosis | Risk factors for early ST | Risk factors for late ST | Risk factors for very late ST

Premature discontinuation of antiplatelet therapy

Incidence | Predictors | Risk associated with premature discontinuation | Risk associated with late discontinuation | Duration of therapy | Failure of therapy | Prevention of premature discontinuation

Prognosis

Recurrence of stent thrombosis | Myocardial infarction

Prevention

Overview | Clinical trial data | Guidelines

Template:WikiDoc Sources